InsidersTradesSigma
Browse the detailed record of transactions filed by Bomma Shilpa, Executive. Insider active across 1 company, notably Aurobindo Pharma Limited. Cumulatively, 3 reports have been published. Activity tracked since 15 June 2021. The latest transaction was filed on 29 June 2021 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Bomma Shilpa is an executive at Aurobindo Pharma Limited, a leading pharmaceutical company. She is involved in managing operations and strategic development for the company, contributing to its commitment to innovation and public health improvement.